Long-term follow-up of hospitalized COVID-19 patients with interstitial lung involvement
The Journal of Infection in Developing Countries · 31.03.2026 · 20 (03) · 342-349
DOI: 10.3855/jidc.21215 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 31.03.2026. Verfasst von Özer Özdemir und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chest Diseases, University of Health Sciences, Dr Suat Seren Chest Diseases and Surgery Training and Research Hospital, Izmir, Turkiye. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, COVID-19. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Data regarding the residual lung findings persisting beyond 12 months from acute infection in patients with COVID-19 with pulmonary involvement are scarce. This study investigates the long-term radiological and functional findings of previously hospitalized COVID-19 patients who had residual pulmonary involvement at 3–6-month follow-up. Methodology: This retrospective cohort study was an extended analysis of a previously published study, including patients with COVID-19 pneumonia hospitalized between June 2020 and March 2021. Residual lung involvement due to COVID-19 pneumonia was classified according to the presence of ground glass opacities, honeycombing, traction bronchiectasis, reticulations, and parenchymal bands.
Results
51 out of the 157 patients with abnormal chest findings in high-resolution computed tomography (HRCT) scans at 3–6-month follow-up were included. Mean age of the study population was 60.5 ± 10.5 years; 35 subjects were male (68.6%). HRCT controls were obtained 25.7 ± 6.36 months after the diagnosis. There was regression of predefined radiological involvement in 39 patients (76.5%), whereas 11 patients (21.6%) exhibited stable findings, and one patient had progressive lung involvement with a usual interstitial pneumonia pattern. Persistent residual parenchymal bands were found mostly in ICU-admitted patients (p = 0.04), and reticulations were seen in patients with a CT severity score > 18 (p = 0.04).
Conclusions
In most patients with pulmonary sequelae, lesions showed improvement after 18 months, with complete resolution in about one third of patients after a 6-month follow-up. There was a correlation between initial severity and persistence of lung abnormalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Chest Diseases, University of Health Sciences, Dr Suat Seren Chest Diseases and Surgery Training and Research Hospital, Izmir, Turkiye.
Zitieren
APA
Özdemir, Ö., Polat, G., Gayaf, M., Güldaval, F., Serçe Unat, D., & Şimşek, T. (2026). Long-term follow-up of hospitalized COVID-19 patients with interstitial lung involvement. The Journal of Infection in Developing Countries, 20(03), 342-349. https://doi.org/10.3855/jidc.21215
Vancouver
Özdemir Ö, Polat G, Gayaf M, Güldaval F, Serçe Unat D, Şimşek T. Long-term follow-up of hospitalized COVID-19 patients with interstitial lung involvement. The Journal of Infection in Developing Countries. 2026;20(03):342-349. doi:10.3855/jidc.21215
BibTeX
@article{zdemir2026,
author = {Özdemir, Özer and Polat, Gülru and Gayaf, Mine and Güldaval, Filiz and Serçe Unat, Damla and Şimşek, Tarık},
title = {Long-term follow-up of hospitalized COVID-19 patients with interstitial lung involvement},
journal = {The Journal of Infection in Developing Countries},
year = {2026},
volume = {20},
number = {03},
pages = {342--349},
doi = {10.3855/jidc.21215}
}
EUVIMED